The National Comprehensive Cancer Network (NCCN) Oncology Research Program (OPR) will support a Phase II randomized trial for lung cancer patients titled TH-138. Joseph Treat,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.